
Ongericimab Injection (JUNSHID®) Approved For Use In China
On October 11, 2024, Junshi Biosciences announced that its self-developed recombinant humanized anti-PCSK9 monoclonal antibody…

On October 11, 2024, Junshi Biosciences announced that its self-developed recombinant humanized anti-PCSK9 monoclonal antibody…

In the fight against severe and chronic auto-inflammatory diseases, Rilonacept Injection has emerged as a…

February 2025 – In a groundbreaking advancement in the treatment of platinum-resistant ovarian cancer, the…

February 2025 — In a significant advancement in the treatment of certain aggressive cancers, Sacituzumab…

In 2024, several new lung cancer treatments, including Unecritinib Fumarate Capsules, Tarlatamab, Zenocutuzumab, Lazertinib and…

February 2025 — In a significant breakthrough for cancer treatment, Loncastuximab Tesirine-lpyl (brand name Zynlonta)…

In the rapidly advancing world of cancer treatment, Lunsumio(Mosunetuzumab) has emerged as a promising new…

In the ever-evolving landscape of oncology, a promising new drug, Zolbetuximab-Clzb for Injection, has made…

In recent years, Vindesine Sulfate For Injection, as a chemotherapeutic drug, has demonstrated remarkable efficacy…

Selumetinib (INN) is sold under the trade name Koselugo and is a medication used to…